Skip to main content

Advertisement

SpringerLink
Log in

Controversies in management of the neck in head and neck cancer

  • Published:
Current Treatment Options in Oncology Aims and scope Submit manuscript

Opinion statement

As definitive external radiation and multimodality organ preservation strategies (eg, combined chemotherapy and radiation therapy [CCRT]) improve, the role of surgery is being re-examined in the management of locally advanced head and neck cancer. Consensus regarding the use of neck dissections for complete responders and incomplete responders has yet to be achieved and the data are surprisingly controversial. A possible benefit from neck dissection after a complete response of the primary tumor after CCRT or definitive external radiation for advanced squamous cell carcinoma of the head and neck may only be anticipated in patients with persisting subclinical neck disease who have no other sites of disease. Some clinicians have even argued that the salvage rate for clinically detectable residual neck disease does not justify neck dissection. Randomized data addressing these questions and a trial addressing the accuracy of new imaging modalities, such as postchemotherapy and postradiation positron emission tomography scanning, across multiple institutions would be appropriate. As a department, we are aggressive in our treatment of isolated residual neck disease after CCRT or definitive external radiation and for patients initially diagnosed with N3 nodal disease. We are investigating the use of adjuvant neck brachytherapy at the time of neck dissection and we are pleased with our early results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Million RR, Cassisi NJ: Management of Head and Neck Cancer. Philadelphia: Lippincott Williams & Wilkins; 1994.

    Google Scholar 

  2. Terz JJ, King ER, Lawrence W Jr: Preoperative irradiation for head and neck cancer: results of a prospective study. Surgery 1981, 89:449–453.

    PubMed  CAS  Google Scholar 

  3. Strong EW, Henschke UK, Nickson JJ, et al.: Preoperative X-ray therapy as an adjunct to radical neck dissection. Cancer 1966, 19:1509–1516.

    Article  PubMed  CAS  Google Scholar 

  4. Vandenbrouck C, Sancho-Garnier H, Chassagne D, et al.: Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer 1980, 46:386–390.

    Article  PubMed  CAS  Google Scholar 

  5. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991, 324:1685-1690.

  6. Fu KK, Pajak TF, Trotti A, et al.: A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7–16. This is the best paper regarding the effectiveness of altered fractionation for definitive management of head and neck cancers. Seventy Gy in 2-Gy daily fractions was beaten by two of three experimental arms.

    Article  PubMed  CAS  Google Scholar 

  7. Bernier J, Domenge C, Eschwege F, et al.: Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: results of EORTC phase III trial 22931 [abstract]. Int J Radiat Oncol Biol Phys 2001, 51:1.

    Article  Google Scholar 

  8. Cooper JS, Pajak TF, Forastiere A, et al.: Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/intergroup phase III trial [abstract]. Proc Am Soc Clin Oncol 2002, 20:903.

    Google Scholar 

  9. Lin A, Kim HM, Terrell JE, et al.: Quality of life after parotid-sparing IMRT for head and neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003, 57:61–70.

    Article  PubMed  Google Scholar 

  10. Byers RM, Wolf PF, Ballantyne AJ: Rationale for elective modified neck dissection. Head Neck Surg 1988, 10:160–167.

    Article  PubMed  CAS  Google Scholar 

  11. Lundahl RE, Foote RL, Bonner JA, et al.: Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis. Int J Radiat Oncol Biol Phys 1998, 40:529–534.

    Article  PubMed  CAS  Google Scholar 

  12. Peters LJ, Goepfert H, Ang KK, et al.: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993, 26:3–11.

    PubMed  CAS  Google Scholar 

  13. Forastiere AA, Berkey BA, Maor M, et al.: Phase III trial to preserve the larynx: induction chemotherapy and radiotherapy versus concomitant chemoradiotherapy versus radiotherapy alone: Intergroup Trial R91-11 [abstract]. Proc Am Soc Clin Oncol 2001, 20:2a.

    Google Scholar 

  14. Calais G, Alfonsi M, Bardet E, et al.: Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999, 91:2081–2086. This paper is probably one of the best papers showing that concurrent chemotherapy adds to the use of 70 Gy in 2-Gy daily fractions for oropharyngeal cancers.

    Article  PubMed  CAS  Google Scholar 

  15. Lefebvre JL, Chevalier D, Luboinski B, et al.: Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996, 88:890–899.

    Article  Google Scholar 

  16. Wolf GT, Fisher SG: Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation. Laryngoscope 1992, 102:934–939.

    Article  PubMed  CAS  Google Scholar 

  17. Bartelink H: Prognostic value of the regression rate of neck node metastases during radiotherapy. Int J Radiat Oncol Biol Phys 1983, 9:993–996.

    PubMed  CAS  Google Scholar 

  18. Bataini JP, Bernier J, Jaulerry C, et al.: Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys 1987, 13:817–824.

    PubMed  CAS  Google Scholar 

  19. Million RR, Cassisi NJ, Mancuso AA, et al.: Management of the neck for squamous cell carcinoma. In Management of Head and Neck Cancer. Edited by Million RR, Cassisi NJ. Philadelphia: J B Lippincott Company; 1994:75–142.

    Google Scholar 

  20. Bernier J, Bataini JP: Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high-dose per fraction radiotherapy: analysis of neck disease response in 1646 cases. Radiother Oncol 1986, 6:87–103.

    Article  PubMed  CAS  Google Scholar 

  21. Bataini JP, Bernier J, Brugere J, et al.: Natural history of neck disease in patients with squamous cell carcinoma of oropharynx and pharyngolarynx. Radiother Oncol 1985, 3:245–255.

    Article  PubMed  CAS  Google Scholar 

  22. Johnson CR, Silverman LN, Clay LB, Schmidt-Ullrich R: Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck: is postradiotherapy neck dissection necessary? Radiat Oncol Investig 1998, 6:52–57.

    Article  PubMed  CAS  Google Scholar 

  23. Peters LJ, Weber RS, Morrison WH, et al.: Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck 1996, 18:552–559.

    Article  Google Scholar 

  24. Strong EW: Preoperative radiation and radical neck dissection. Surg Clin North Am 1969, 49:271–276.

    PubMed  CAS  Google Scholar 

  25. Newkirk KA, Cullen KJ, Harter KW, et al.: Planned neck dissection for advanced primary head and neck malignancy treated with organ preservation therapy: disease control and survival outcomes. Head Neck 2001, 23:73–79.

    Article  PubMed  CAS  Google Scholar 

  26. Stenson KM, Haraf DJ, Pelzer H, et al.: The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000, 126:950–956.

    PubMed  CAS  Google Scholar 

  27. Ahmed KA, Robbins KT, Wong F, et al.: Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 2000, 110:1789–1793.

    Article  PubMed  CAS  Google Scholar 

  28. Grabenbauer GG, Rodel C, Ernst-Stecken A, et al.: Neck dissection following radiochemotherapy of advanced head and neck cancer: for selected cases only? Radiother Oncol 2003, 66:57–63.

    Article  PubMed  Google Scholar 

  29. Wanebo H, Chougule P, Ready N, et al.: Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV). Ann Surg Oncol 2001, 8:644–650.

    Article  PubMed  CAS  Google Scholar 

  30. Narayan K, Crane CH, Kleid S, et al.: Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all? Head Neck 1999, 21:606–613.

    Article  PubMed  CAS  Google Scholar 

  31. Mabanta SR, Mendenhall WM, Stringer SP, et al.: Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck 1999, 21:591–594.

    Article  PubMed  CAS  Google Scholar 

  32. Adams GL, Madison M, Remley K, et al.: Preoperative permanent balloon occlusion of internal carotid artery in patients with advanced head and neck squamous cell carcinoma. Laryngoscope 1999, 109:460–466.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, 111 East 210th Street, 10467, Bronx, NY, USA

    Jonathan J. Beitler MD, MBA, FACR

Authors
  1. Madhur Garg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan J. Beitler MD, MBA, FACR
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garg, M., Beitler, J.J. Controversies in management of the neck in head and neck cancer. Curr. Treat. Options in Oncol. 5, 35–40 (2004). https://doi.org/10.1007/s11864-004-0004-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11864-004-0004-8

Keywords

Search

Navigation